Skip to content
Governance Register

← US public companies

Landos Biopharma, Inc.

SEC CIK 1785345 · LABP · last insider filing 2024-05-23

Directors (from insider filings)

NameCapacity as filedFilings
Mayleben Timothy M Director · Interim CEO filed 2021 - 2024
Girao Tiago Director filed 2021 - 2024
Adsett Roger Director filed 2022 - 2024
Oakes Gregory Director · Chief Executive Officer filed 2022 - 2024
Callori Fred Director filed 2021 - 2024
Garabedian Christopher Nishan Director filed 2021 - 2024
Batycky Alka Director filed 2023 - 2024
Bassaganya-Riera Josep Director · Chairman, President and CEO filed 2021 - 2023
Edelman Joseph Director filed 2021 - 2023
Perceptive Advisors LLC Director filed 2021 - 2023
Perceptive Life Sciences Master Fund LTD Director filed 2021 - 2023
Perceptive Xontogeny Venture Fund, LP Director filed 2021 - 2023
Wong Roderick Director filed 2021 - 2022
Xontogeny, LLC Director filed 2021 - 2021
Poukalov Konstantin Director filed 2021 - 2021
Colombel Jean-Frederic Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Cataldi Fabio Chief Medical Officer filed 2022 - 2024
Truesdell Patrick Vice President and Controller filed 2022 - 2023
Bitar Patricia L Interim CFO filed 2021 - 2021
Chauhan Jyoti ED, Global Clinical Operations filed 2021 - 2021
Hontecillas Raquel Chief Scientific Officer filed 2021 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.